End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.05 CNY | +0.29% | -2.12% | +1.91% |
Mar. 22 | Shanghai Pharmaceuticals Gets Nod to Register Amiodarone Hydrochloride Injection | MT |
Mar. 20 | Shanghai Pharma Names Chairman; Vice Chairman Resigns | MT |
Sales 2023 * | 263B 36.34B | Sales 2024 * | 296B 40.93B | Capitalization | 57.27B 7.93B |
---|---|---|---|---|---|
Net income 2023 * | 5.4B 747M | Net income 2024 * | 6.18B 855M | EV / Sales 2023 * | 0.25 x |
Net Debt 2023 * | 9.11B 1.26B | Net Debt 2024 * | 4.68B 648M | EV / Sales 2024 * | 0.21 x |
P/E ratio 2023 * |
11.6
x | P/E ratio 2024 * |
9.93
x | Employees | 47,877 |
Yield 2023 * |
2.53% | Yield 2024 * |
3.17% | Free-Float | 45.1% |
1 day | +0.29% | ||
1 week | -2.12% | ||
Current month | -5.96% | ||
1 month | -5.01% | ||
3 months | +4.03% | ||
6 months | -5.85% | ||
Current year | +1.91% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Zhong Li
PSD | President | 54 | 19-06-26 |
Bo Shen
PSD | President | 51 | 13-06-04 |
Ye Lu
IRC | Investor Relations Contact | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bo Shen
PSD | President | 51 | 13-06-04 |
Yong Zhong Li
PSD | President | 54 | 19-06-26 |
Manson Fok
BRD | Director/Board Member | 67 | 19-06-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.86% | 2 M€ | -16.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 17.05 | +0.29% | 11,079,840 |
24-03-26 | 17 | -0.58% | 10,110,400 |
24-03-25 | 17.1 | 0.00% | 11,555,620 |
24-03-22 | 17.1 | -1.89% | 16,628,300 |
24-03-21 | 17.43 | +0.06% | 10,576,980 |
End-of-day quote Shanghai S.E., March 26, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.91% | 7.92B | |
+16.48% | 70.86B | |
+11.65% | 27.37B | |
-1.96% | 8.14B | |
-25.23% | 7.51B | |
+1.40% | 4.65B | |
+10.56% | 4.08B | |
+2.13% | 4.12B | |
-4.65% | 3.92B | |
+11.60% | 3.33B |